EHC - ENCMPS HLTH CRP （）

Encompass Health Corporation with ticker code (EHC) have now 11 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 76 and 58 and has a mean target at 64.64. Now with the previous closing price of 57.12 this indicates there is a potential upside of 13.2%. There is a 50 day moving average of 51.33 and the 200 day MA is 51.5. The market cap for the company is $5,605m. Find out more information at: https://www.encompasshealth.com [stock_market_widget type="chart" template="basic" color="green" assets="EHC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $6,343m based on the market concensus. Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

We continue to see long-term value in Encompass Health Corporation. See why we rate EHC stock a buy on fundamental value.

Encompass Health Corporation with ticker code (EHC) now have 11 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 76 and 58 with the average target price sitting at 64.64. Now with the previous closing price of 56.64 this now indicates there is a potential upside of 14.1%. The day 50 moving average is 50.49 and the 200 moving average now moves to 51.21. The company has a market cap of $5,620m. You can visit the company''s website by visiting: https://www.encompasshealth.com [stock_market_widget type="chart" template="basic" color="green" assets="EHC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $6,414m based on the market concensus. Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Encompass Health Corporation with ticker code (EHC) have now 12 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 76 and 58 and has a mean target at 64.5. With the stocks previous close at 54.64 this would imply there is a potential upside of 18.0%. There is a 50 day moving average of 49.39 and the 200 moving average now moves to 50.93. The company has a market capitalisation of $5,432m. Visit the company website at: https://www.encompasshealth.com [stock_market_widget type="chart" template="basic" color="green" assets="EHC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $6,412m based on the market concensus. Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Encompass Health Corporation (NYSE:NYSE:EHC) Q3 2022 Results Conference Call October 27, 2022 10:00 AM ET Company Participants Mark Miller - Chief IR Officer Mark Tarr - President and CEO…

BIRMINGHAM, Ala. , Feb. 28, 2022 /PRNewswire/ -- Encompass Health Corporation ("Encompass Health" or the "Company") (NYSE: EHC ), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals and home health and hospice agencies, in response to recent discussions with stockholders, including JANA Partners LLC, today provided the following updates with respect to its previously disclosed Board refreshment process and planned separation of the Company''s home health and hospice business, Enhabit. The Company confirms that, in connection with its previously announced Board refreshment process, the size of the Board will consist of no more than 12 directors as of the conclusion of the 2022 Annual Meeting of Stockholders. The Company''s slate of directors who will stand for election to the Board will be set forth in the Company''s proxy statement materials when filed. The Company continues to expect to …

In addition, management''s discussion and analysis of our results of operations and cash flows for the year ended December 31, 2020 compared to the year ended December 31, 2019 may be found in, Part II, Item 7, Management''s Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10- K for the year ended December 31,… The post ENCOMPASS HEALTH CORP – 10-K – Management''s Discussion and Analysis of Financial Condition and Results of Operations appeared first on InsuranceNewsNet .

Encompass Health (EHC) and Lee Healthcare, a subsidiary of Lee Health, will collaborate to jointly own and operate 2 new inpatient rehabilitation hospitals in Southwest…

Encompass Health Corporation (NYSE:EHC) declaes $0.28/share quarterly dividend, in line with previous.Forward yield 1.71%Payable April 18; for shareholders of record April 1; ex-div March…

Victory Capital Management Inc. lifted its holdings in shares of Encompass Health Co. (NYSE:EHC) by 0.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,696,420 shares of the companys stock after buying an additional 5,878 shares during the period. Victory []

WINTON GROUP Ltd cut its holdings in shares of Encompass Health Co. (NYSE:EHC) by 10.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,899 shares of the companys stock after selling 968 shares during the period. WINTON GROUP Ltds holdings in Encompass [] The post Encompass Health Co. (NYSE:EHC) Shares Sold by WINTON GROUP Ltd appeared first on ETF Daily News .

The ENCOMPASS HEALTH CORPORATION POLITICAL ACTION COMMITTEE successfully filed their F3XN DECEMBER MONTHLY with the coverage period of 11/01/2021 to 11/30/2021 and a confirmation ID of FEC-1553171 *********CommitteeId: C00414649 | FilingId: 1553171 | FormType: F3XN | CoverageFrom: 11/01/2021 | CoverageThrough: 11/30/2021 | ReportType: DECEMBER MONTHLY*********

Foster & Motley Inc. cut its position in shares of Encompass Health Co. (NYSE:EHC) by 0.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 34,897 shares of the companys stock after selling 334 shares during the period. Foster & Motley Inc.s []

Foster & Motley Inc. decreased its position in Encompass Health Co. (NYSE:EHC) by 0.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 34,897 shares of the companys stock after selling 334 shares during the quarter. Foster & Motley Inc.s holdings in Encompass []